KURA ONCOLOGY INC's ticker is KURA and the CUSIP is 50127T109. A total of 116 filers reported holding KURA ONCOLOGY INC in Q3 2019. The put-call ratio across all filers is - and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $1,168,000 | +10.1% | 63,700 | -3.5% | 0.02% | +41.7% |
| Q1 2022 | $1,061,000 | -1.5% | 65,980 | +14.7% | 0.01% | +9.1% |
| Q3 2021 | $1,077,000 | -10.9% | 57,500 | -0.9% | 0.01% | -8.3% |
| Q2 2021 | $1,209,000 | -26.3% | 58,000 | 0.0% | 0.01% | -29.4% |
| Q1 2021 | $1,640,000 | -13.4% | 58,000 | 0.0% | 0.02% | -22.7% |
| Q4 2020 | $1,894,000 | +28.8% | 58,000 | +20.8% | 0.02% | +10.0% |
| Q3 2020 | $1,471,000 | +159.0% | 48,000 | -15.9% | 0.02% | +81.8% |
| Q1 2020 | $568,000 | -73.8% | 57,100 | -63.8% | 0.01% | -67.6% |
| Q4 2019 | $2,170,000 | -14.0% | 157,800 | -5.1% | 0.03% | -27.7% |
| Q3 2019 | $2,523,000 | -11.8% | 166,300 | +14.5% | 0.05% | -4.1% |
| Q2 2019 | $2,859,000 | +488.3% | 145,200 | +395.6% | 0.05% | +81.5% |
| Q1 2019 | $486,000 | – | 29,300 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| EcoR1 Capital, LLC | 3,766,852 | $57,633,000 | 6.49% |
| GREAT POINT PARTNERS LLC | 2,197,283 | $33,618,000 | 5.74% |
| Sio Capital Management, LLC | 392,027 | $5,998,000 | 3.38% |
| BVF INC/IL | 1,353,846 | $20,714,000 | 2.50% |
| Boxer Capital, LLC | 844,789 | $12,925,000 | 2.36% |
| ALETHEA CAPITAL MANAGEMENT, LLC | 89,673 | $1,372,000 | 2.18% |
| Minerva Advisors LLC | 170,921 | $2,607,000 | 1.41% |
| NEXTHERA CAPITAL LP | 445,550 | $6,817,000 | 1.26% |
| DAFNA Capital Management LLC | 117,281 | $1,794,000 | 0.97% |
| PFM Health Sciences, LP | 1,752,124 | $26,807,000 | 0.64% |